A Preliminary Study into the Sensitivity of Disease Activity Detection by Serial Weekly Magnetic Resonance Imaging in Multiple Sclerosis

Overview

Journal J Neurol Neurosurg Psychiatry

Publisher BMJ Publishing Group

Specialties Neurology
Neurosurgery
Psychiatry

Date 1996 Mar 1

PMID 8609517

Citations 10

Authors

M Lai

T Hodgson

M Gawne-Cain

S Webb

D MacManus

W I McDonald

A J Thompson

D H Miller

Affiliations

Soon will be listed here.

Abstract

Long TR and gadolinium enhanced spin echo brain MRI was performed weekly for three months in three patients with relapsing-remitting or secondary progressive multiple sclerosis. During the study, 38 new enhancing lesions were seen; 11 showed enhancement for less than four weeks, and two enhanced on only one scan. All 16 new lesions seen on long TR scans showed initial enhancement. When only every fourth (monthly) scan was analysed, a total of 33 new enhancing lesions were seen. Subject to confirmation in a larger cohort, the results suggest: (a) that blood brain barrier leakage is an invariable event in new lesion development in relapsing-remitting and secondary progressive multiple sclerosis; (b) the small increase in sensitivity of weekly scanning does not justify its use in preference to monthly scanning when monitoring treatments.

Citing Articles

Prognostic value of white matter lesion shrinking in early multiple sclerosis: An intuitive or naïve notion?.

Pongratz V, Schmidt P, Bussas M, Grahl S, Gaser C, Berthele A Brain Behav. 2019; 9(12):e01417.

PMID: 31557419 PMC: 6908875. DOI: 10.1002/brb3.1417.

'No evidence of disease activity' - is it an appropriate surrogate in multiple sclerosis?.

Hegen H, Bsteh G, Berger T Eur J Neurol. 2018; 25(9):1107-e101.

PMID: 29687559 PMC: 6099351. DOI: 10.1111/ene.13669.

Multiple sclerosis: the evolving diagnostic criteria for multiple sclerosis.

Trojano M Nat Rev Neurol. 2011; 7(5):251-2.

PMID: 21537354 DOI: 10.1038/nrneurol.2011.55.

New imaging techniques in the diagnosis of multiple sclerosis.

Fu Y, Talavage T, Cheng J Expert Opin Med Diagn. 2009; 2(9):1055-65.

PMID: 19337386 PMC: 2662586. DOI: 10.1517/17530050802361161.

Imaging of multiple sclerosis: role in neurotherapeutics.

Bakshi R, Minagar A, Jaisani Z, Wolinsky J NeuroRx. 2005; 2(2):277-303.

PMID: 15897951 PMC: 1064992. DOI: 10.1602/neurorx.2.2.277.

References

Poser C, Paty D, Scheinberg L, McDonald W, Davis F, Ebers G . New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983; 13(3):227-31. DOI: 10.1002/ana.410130302. View

Filippi M, Campi A, Martinelli V, Colombo B, Yousry T, Canal N . Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry. 1995; 59(5):540-4. PMC: 1073722. DOI: 10.1136/jnnp.59.5.540. View

Isaac C, Li D, GENTON M, Jardine C, GROCHOWSKI E, Palmer M . Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology. 1988; 38(10):1511-5. DOI: 10.1212/wnl.38.10.1511. View

Bastianello S, Pozzilli C, Bernardi S, Bozzao L, Fantozzi L, Buttinelli C . Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology. 1990; 40(4):591-5. DOI: 10.1212/wnl.40.4.591. View

Kermode A, Thompson A, Tofts P, MacManus D, Kendall B, KINGSLEY D . Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain. 1990; 113 ( Pt 5):1477-89. DOI: 10.1093/brain/113.5.1477. View

Thompson A, Kermode A, Wicks D, MacManus D, Kendall B, KINGSLEY D . Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol. 1991; 29(1):53-62. DOI: 10.1002/ana.410290111. View

Thompson A, Miller D, Youl B, MacManus D, Moore S, Kingsley D . Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration. Neurology. 1992; 42(1):60-3. DOI: 10.1212/wnl.42.1.60. View

Barkhof F, Valk J, Hommes O, Scheltens P, Nauta J . Gadopentetate dimeglumine enhancement of multiple sclerosis lesions on long TR spin-echo images at 0.6 T. AJNR Am J Neuroradiol. 1992; 13(4):1257-9. PMC: 8333585. View

Capra R, Marciano N, Vignolo L, Chiesa A, Gasparotti R . Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis. Arch Neurol. 1992; 49(7):687-9. DOI: 10.1001/archneur.1992.00530310029008. View

10.

Barkhof F, Scheltens P, Frequin S, Nauta J, Tas M, Valk J . Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. AJR Am J Roentgenol. 1992; 159(5):1041-7. DOI: 10.2214/ajr.159.5.1414773. View

11.

McFarland H, Frank J, Albert P, Smith M, Martin R, Harris J . Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol. 1992; 32(6):758-66. DOI: 10.1002/ana.410320609. View

12.

Rodriguez M, Scheithauer B, Forbes G, Kelly P . Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc. 1993; 68(7):627-36. DOI: 10.1016/s0025-6196(12)60597-7. View

13.

Miller D, Barkhof F, Nauta J . Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain. 1993; 116 ( Pt 5):1077-94. DOI: 10.1093/brain/116.5.1077. View

14.

Finelli D, Hurst G, Gullapali R, BELLON E . Improved contrast of enhancing brain lesions on postgadolinium, T1-weighted spin-echo images with use of magnetization transfer. Radiology. 1994; 190(2):553-9. DOI: 10.1148/radiology.190.2.8284415. View

15.

Revesz T, Kidd D, Thompson A, BARNARD R, McDonald W . A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain. 1994; 117 ( Pt 4):759-65. DOI: 10.1093/brain/117.4.759. View

16.

Khoury S, Guttmann C, Orav E, Hohol M, Ahn S, Hsu L . Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden. Neurology. 1994; 44(11):2120-4. DOI: 10.1212/wnl.44.11.2120. View

17.

Kurtzke J . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983; 33(11):1444-52. DOI: 10.1212/wnl.33.11.1444. View